Endpoint Clinical

Endpoint Clinical operates in the digital health and clinical trial technology sector, providing critical RTSM infrastructure that ensures the correct allocation of treatments and management of drug supplies in clinical studies. The company differentiates itself through a model of 'operational vigilance,' combining advanced, multi-generational software platforms (PULSE and Elosity) with deep, experienced support services. With a track record of over 2,000 studies and 650,000+ patients, it serves a global market, helping to de-risk and streamline complex clinical trial logistics. As a private company, it is positioned as a key enabler in the growing trend toward decentralized and more efficient clinical trials.

Proprietary Randomization and Trial Supply Management (RTSM) software platforms named PULSE (dynamic, customizable) and Elosity (next-generation, multi-tenant), integrated with tailored support services for clinical trial operations.

Endpoint Clinical competes in the RTSM segment against large clinical technology platforms like Medidata (part of Dassault Systèmes) and Veeva Vault RTSM, as well as other specialized providers such as Almac Group, Anju Software, and 4G Clinical. Its differentiation is based on deep service integration, operational expertise, and a focused product strategy, rather than being one module within a broader suite.